Differential expression of and responsiveness to transforming growth factor-β (TGF-β) isoforms in hormone-dependent and independent lines of mouse mammary tumors

Transforming growth factor-β2 (TGF-β2) and -β3 mRNA expressions were studied in ductal hormone-dependent (HD) and -independent (HI) in vivo lines of the medroxyprogesterone acetate (MPA)-induced mammary tumor model in Balb/c mice. MPA treatment of HD tumors induced a significant decrease in TGF-β2 a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Viegas, M.H., Salatino, M., Goin, M., Peters, G., Labriola, L., Costa da Cunha, J., Lanari, C., Charreau, E.H., Elizalde, P.V.
Formato:	JOUR
Materias:	-132 And -β3 Mammary adenocarcinomas Progestins Transforming growth factors-β1 cyclin D1 isoprotein messenger RNA transforming growth factor beta affinity labeling animal article Bagg albino mouse cell culture epithelium cell experimental neoplasm female fibroblast gene expression regulation metabolism mouse neoplasm Northern blotting Affinity Labels Animals Blotting, Northern Cyclin D1 Epithelial Cells Female Fibroblasts Gene Expression Regulation, Neoplastic Mammary Neoplasms, Experimental Mice Mice, Inbred BALB C Neoplasms, Hormone-Dependent Protein Isoforms RNA, Messenger Transforming Growth Factor beta Tumor Cells, Cultured
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_0361090X_v23_n5_p375_Viegas
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Differential expression of and responsiveness to transforming growth factor-β (TGF-β) isoforms in hormone-dependent and independent lines of mouse mammary tumors
Publicado: (1999)

Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas
Publicado: (1995)

Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas
por: Elizalde, P.V., et al.

Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, Patricia Virginia, et al.
Publicado: (1990)

Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, P.V., et al.

Mechanisms of cell cycle arrest in response to TGF-β in progestin- dependent and -independent growth of mammary tumors
Publicado: (2001)

Mechanisms of cell cycle arrest in response to TGF-β in progestin- dependent and -independent growth of mammary tumors
por: Salatino, M., et al.

Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary
Publicado: (2011)

Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary
por: Recouvreux, M.V., et al.

Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c
Publicado: (1997)

Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c
por: Elizalde, P.V., et al.

Transforming growth factor β1 regulates follistatin mRNA expression during in vitro bovine granulosa cell differentiation
Publicado: (2006)

Transforming growth factor β1 regulates follistatin mRNA expression during in vitro bovine granulosa cell differentiation
por: Fazzini, M., et al.

Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells
Publicado: (2002)

Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells
por: Renner, U., et al.

Sex differences in the pituitary transforming growth factor-β1 system: Studies in a model of resistant prolactinomas
Publicado: (2013)

Sex differences in the pituitary transforming growth factor-β1 system: Studies in a model of resistant prolactinomas
por: Recouvreux, M.V., et al.

αtransforming growth factorlike activities and bifunctional regulators of cell growth in human malignant neoplasms
Publicado: (1990)

αtransforming growth factorlike activities and bifunctional regulators of cell growth in human malignant neoplasms
por: Elizalde, P.V., et al.

Interaction between the aryl hydrocarbon receptor and transforming growth factor-β signaling pathways: Evidence of an asymmetrical relationship in rat granulosa cells
por: Bussmann, Ursula A., et al.
Publicado: (2008)

Interaction between the aryl hydrocarbon receptor and transforming growth factor-β signaling pathways: Evidence of an asymmetrical relationship in rat granulosa cells
por: Bussmann, U.A., et al.

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability
Publicado: (1996)

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability
por: Guerra, F.K., et al.

Evidence for a role of the alternatively spliced ED-I sequence of fibronectin during ovarian follicular development
por: Colman Lerner, Alejandro Ariel, et al.
Publicado: (1999)

Evidence for a role of the alternatively spliced ED-I sequence of fibronectin during ovarian follicular development
por: Colman-Lerner, A., et al.
Publicado: (1999)

Evidence for a role of the alternatively spliced ED-I sequence of fibronectin during ovarian follicular development
por: Colman-Lerner, A., et al.
Publicado: (1999)

Evidence for a role of the alternatively spliced ED-I sequence of fibronectin during ovarian follicular development
por: Colman-Lerner, A., et al.

Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential
Publicado: (2006)

Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential
por: Urtreger, A.J., et al.

Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
Publicado: (2005)

Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
por: Hofer, E.L., et al.

Involvement of KLF14 and egr-1 in the TGF-beta1 action on Leydig cell proliferation
Publicado: (2013)

Involvement of KLF14 and egr-1 in the TGF-beta1 action on Leydig cell proliferation
por: Gonzalez, C.R., et al.

Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients
Publicado: (2002)

Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients
por: Honegger, A.E., et al.

Activin and follistatin in rat mammary gland
por: Bussmann, Ursula A., et al.
Publicado: (2004)

Activin and follistatin in rat mammary gland
por: Bussmann, U.A., et al.

Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC
por: Benedetti, Lorena Gabriela, et al.
Publicado: (2017)

Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC
por: Guttlein, L.N., et al.

Early and adult hippocampal TGF-β1 overexpression have opposite effects on behavior
por: Depino, Amaicha Mara, et al.
Publicado: (2011)